Clinical trial

Genetics of Response to Canagliflozin

NCT02891954

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2016-09-01

PhasePHASE1

Study timeline

Study start (actual)2016-09-01Date precision: month

Registry last updated2025-12-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

CanagliflozinDRUG · verified · RxNorm: canagliflozin

Sponsors & collaborators

University of Maryland, Baltimorelead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02891954 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.